Heidi M. Mansour

ORCID: 0000-0003-3993-9210
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inhalation and Respiratory Drug Delivery
  • Transplantation: Methods and Outcomes
  • Advanced Drug Delivery Systems
  • Microencapsulation and Drying Processes
  • Drug Solubulity and Delivery Systems
  • Pulmonary Hypertension Research and Treatments
  • Nanoparticle-Based Drug Delivery
  • Asthma and respiratory diseases
  • Aerosol Filtration and Electrostatic Precipitation
  • Renal Transplantation Outcomes and Treatments
  • Cystic Fibrosis Research Advances
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Lipid Membrane Structure and Behavior
  • Advancements in Transdermal Drug Delivery
  • Polyomavirus and related diseases
  • Surfactants and Colloidal Systems
  • Mechanical Circulatory Support Devices
  • Respiratory viral infections research
  • Ion channel regulation and function
  • Neuropeptides and Animal Physiology
  • Respiratory Support and Mechanisms
  • Organ Transplantation Techniques and Outcomes
  • Ion Channels and Receptors
  • Viral Infections and Immunology Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research

University of Arizona
2014-2025

Florida International University
2021-2025

University of Montana
2013-2025

Vaccine & Gene Therapy Institute of Florida
2025

National Cancer Institute
2014-2024

Benha University
2018-2024

Dr. Herbert & Nicole Wertheim Family Foundation
2024

Royal Society of Chemistry
2023

The Ohio State University
2012-2023

Texas A&M University
2023

The impact of pulmonary hypertension (PH) on survival in cystic fibrosis (CF) remains unclear.To determine the influence PH CF population.The United Network for Organ Sharing database was queried from 1987 to 2013 identify first-time lung transplant candidates who were tracked wait list entry date until death or censoring PH. Using right heart catheterization measurements, mild defined as mean artery pressure greater than equal 25 mm Hg and severe 35 Hg.Of 2,781 patients, 2,100 used...

10.1164/rccm.201407-1382oc article EN American Journal of Respiratory and Critical Care Medicine 2014-09-15

Nanomedicine is making groundbreaking achievements in drug delivery. The versatility of nanoparticles has given rise to its use respiratory delivery that includes inhalation aerosol by the nasal route and pulmonary route. Due unique features route, research exploring for poorly absorbed systemically unstable drugs been increasing. successfully used macromolecules like proteins, peptides, vaccines, continues be examined with small molecules, DNA, siRNA, gene therapy. Phospholipid nanocarriers...

10.3390/pharmaceutics6020333 article EN cc-by Pharmaceutics 2014-06-20

Autophagy is activated when the neonatal brain exposed to hypoxia ischemia (HI), but mechanisms underlying its activation and role in neuronal cell death associated with HI unclear. We have previously shown that reactive oxygen species (ROS) derived from nicotinamide adenine dinucleotide phosphate (NADPH) oxidase play an important HI-mediated death. Thus, aim of this study was determine if ROS involved autophagy injury a protective or deleterious pathway. Initial electron microscopy data...

10.1016/j.redox.2015.06.016 article EN cc-by-nc-nd Redox Biology 2015-07-01

The purpose was to design and characterize inhalable microparticulate/nanoparticulate dry powders of mannitol with essential particle properties for targeted powder delivery cystic fibrosis mucolytic treatment by dilute organic solution spray drying, and, in addition, tailor correlate aerosol dispersion performance delivered as inhalers based on spray-drying conditions solid-state physicochemical properties.Organic advanced drying from followed comprehensive characterization vitro...

10.1089/jamp.2013.1078 article EN Journal of Aerosol Medicine and Pulmonary Drug Delivery 2014-02-06

Abstract: The aim of this study was to design and develop respirable antibiotics moxifloxacin (MOXI) hydrochloride ofloxacin (OFLX) microparticles nanoparticles, multifunctional particles with or without lung surfactant 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) for targeted dry powder inhalation delivery as a pulmonary nanomedicine. Particles were rationally designed produced by advanced spray-drying particle engineering from an organic solution in closed mode (no water) dilute...

10.2147/ijn.s48631 article EN cc-by-nc International Journal of Nanomedicine 2013-09-01
Coming Soon ...